Introduction
From among gynecologic cancers, epithelial ovarian cancer (EOC) is the major cause of mortalities in the United States, accounting for 3.6% of all types of gynecologic cancers (3rd rank) throughout the world (Jemal et al., 2010) , while less than 40% of woman afflicted with ovarian cancer are treated (Siegel et al., 2015) . A standard management for EOC patients involves a primary cytoreductive surgery followed by adjuvant chemotherapy if needed (Fader and Rose, 2007) . Still, a poor overall prognosis is rehearsed for patients with advanced EOC despite improved surgical techniques and effectively developed chemotherapy (Markman et al., 2001; Fader and Rose, 2007) . A major reason for this poor treatment is that most EOC patients are frequently involved in an advanced stage of the disease. Furthermore, other characteristics such as, race, age, histologic type, grade, tumor marker, and residual tumor after surgery are required to be identified as prognostic factors (Fathalla, risk groups. Thus, it is vital to be able to access reliable prognostic markers when designing treatment plans to discuss with the patients since clinical management decisions are often challenging (Rochet et al., 2012) . Diagnostic sensitivity can be improved via hematological, immunological, and inflammatory markers studied through CA-125 advanced technology. In addition, it is suggested to use some parameters of CBC panel in the diagnosis and prognosis of the disease (Yildirim et al., 2014) . Clinical outcomes are strongly affected by the immune response of the host to ovarian cancer (Milne et al., 2012) . Neutrophil and the lymphocyte counts were found to increase and relatively decrease as a result of the systemic inflammatory response, respectively. Moreover, a correlation was seen between thrombocytosis associated with the current tumor aggressiveness and quick prognosis for the relevant high recurrence rate. NLR enhancement of epithelial ovarian cancers was discovered to correlate with adverse clinical outcomes (Kokcu et al., 2014; Yildirim et al., 2014 ). An advanced stage of EOC led to the inoperability of preoperative thrombocytosis (Li et al., 2004) . Attempting to improve NLR prognostic function, a high NLR was reported to associate with an adverse OS in numerous solid tumors in few studies. NLR accounts for an inexpensive biomarker readily available (Templeton et al., 2014 ). An investigation on EOC (Asher et al., 2011) was even indicative of the better diagnostic performance of PLR than NLR. Nonetheless, some unfavorable clinicopathological features were observed to be associated with an augmentation in neutrophils, platelets, NLR, or PLR in the previous clinical studies on many cancers (Thavaramara et al., 2011) . The purpose of the current research was to assess the effects of PLR and NLR parameters from CBC panel on the prediction of EOC surgical outcome.
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Materials and Methods
Medical record of patients diagnosed with epithelial ovarian cancer who underwent primary staging exploratory laparotomy at Emam Hossein hospital, Department of Gynecology and Obstetrics between January 2005 and December 2015 were reviewed and 200 patients were collected. The study included 168 patients and 32 patients were excluded. The exclusion criteria were: fertility spairing surgery, incomplete CBC before surgery, insufficient medical history, bone marrow suppression, current infection, any medical condition which influences CBC markers, previous history of local or systemic infection, any medication that is related to patients' inflammatory condition such as corticosteroids and hematologic malignancy. CA-125 was recorded as the primary tumor marker. The cut-off value for CA-125 was 35 IU/ml.
Patients' preoperative data, including demographic features, complete blood count with differentials, tumor histologic type, grade, stage, optimal or suboptimal debulking and serum CA-125 levels were retrospectively analyzed. The relationship between the preoperative values of WBC, platelet number, NLR, PLR and tumor features, including stage and CA-125 levels were evaluated. Optimal surgery was defined when the size of each foci of residual disease after surgery was <1cm.The selected CBC is the nearest one to the surgery.
Role based on data from many previous reports (Li et al., 2004) . NLR of 2.6 and PLR of 200 was used as a cut-off level based on finding from our previous study reporting prognostic role of NLR and PLR in EOC patients (Asher et al., 2011; Thavaramara et al., 2011) . Cut-off values, sensitivity, specificity, PPD, and NPD values were calculated for all cases. In terms of the results achieved, p<0.05 was statistically considered to be a significant difference between the groups at a confidence interval of 95%.
Statistical analysis
Categorical variables were represented by count with percentage, and continuous variables were represented by mean with standard deviation. Independent sample t-test, Mann-Whitney test, and chi-squared test were applied to compare groups. The area under the roc curve (AUC), Sensitivity, Specify, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) were calculated as accuracy measures. Best cut points were obtained by using the optimal sensitivity and specificity values determined by the ROC curves. The AUCs were 
Results
The study included 168 women diagnosed with epithelial ovarian cancer who underwent primary staging exploratory laparotomy. Mean age of patients were 52.1 ranged (23-88), the number of cases according to stages was as follows: stage I: 31, stage II: 11, stage III: 104, stage IV: 22. The number of cases according to surgical outcome was optimal 118 (70.2%) and suboptimal 50 (29.8%) and comparisons were performed between these two groups. Comparison of hematologic parameters between the optimal and suboptimal surgical outcome was shown in Table 1 . Among the hematologic parameters, NLR, and PLR were significantly elevated in suboptimal surgical outcome (p<0.001, p<0.001 respectively).
Figure1 shows receiver operating characteristic of PLR, NLR, and PLT for prediction of surgical outcome. The area under the roc curves (AUC) for predicting surgical outcome were obtained 0.877 (95% CI: 0.82-0.92) for PLR, 0.836 (95% CI: 0.77-0.89) for NLR, and 0.742 (95% CI: 0.67-081) for PLT. Pair-wise comparisons between AUCs of these ratios show that there wasn't any significant difference between prediction validity of PLR and NLR (p=0.246), but PLR had a better prediction that PLT (p<0.001). The best cut off points of PLR, NLR, and PLT for predicting surgical outcome was 293, 192, and 3, respectively. The predictive values of these ratios are represented in table 2.
Discussion
Different prognostic factors such as, age, race, stage, grade, cell type, tumor marker, and residual tumor after surgery were reported to predict EOC outcome by various studies (Kodama et al., 1997; Li et al., 2004) . Based on the pathologic characteristics of cancer, any prognostic factors, except for age, race, and tumor marker, are capable of being evaluated during or after surgery. Attempting to assess a prognostic role in EOC, many studies have recently included CBC for a pre-operative laboratory evaluation. Such blood components as neutrophil and platelet counts (Levin and Conley, 1964; Li et al., 2004; Soonthornthum et al., 2007) , as well as NLR (Cho et al., 2009 ) and lately PLR (Asher et al., 2011) have been of a particular interest. As an independent EOC prognostic factor, platelet count showed to have a role in thrombocytosis accompanied with an inoperable more advanced cancer in many early studies (Levin and Conley, 1964; Li et al., 2004; Soonthornthum et al., 2007) . Also, the prognostic roles of NLR and PLR were investigated in some other studies, the results of which were incongruent (Cho et al., 2009) . Although a significant association of pre-operative NLR ≥ 3 and suboptimal surgery was found in this research, Cho et al. (Cho et al., 2009 ) discovered a poor survival outcome was accompanied with NLR ≥ 2.6 and enhanced CA125. PLR, NLR and PLT functions were analyzed and compared for the possible EOC surgical outcome in the present investigation. A modest predictive value was found for each of these blood components as well as their ratios (e.g. platelet count, PLR or NLR) for the determination of a residue after surgery. Yet, from among the mentioned indicators, PLR demonstrated to have a more improved function.
Consequently, a poor surgical outcome was seen to significantly associate with NLR ≥ 3, PLR ≥ 192, and PLT ≥ 293000 in the analyses.
Though not reaching a statistical significance in his study on PLR and NLR in 84 pancreatic cancer patients, Bhatti et al. (Bhatti et al., 2010 ) discovered shorter and poorer survivals were significantly and tendingly associated only with NLR ≥ 4 and PLR ≥ 200, respectively (Bhatti et al., 2010) . To determine NLR predictive value, a cutoff value of 3 was used and a better function was found with PLR at either 3 or 4 compared to NLR in our study. In another study of NLR and PLR conducted on 324 gastric cancer patients by Wang et al. (Wang et al., 2012), a combination of C-reactive protein and albumin as prognostic indicators were used for survival compared to the Glasgow Prognostic Score. Except for the Glasgow Prognostic Score, NLR or PLR were not found to independently associate with an overall disease-free survival (Wang et al., 2012) . Nevertheless, PLR was reported to have a significant prognostic role in the study of Smith et al. (Smith et al., 2008) , who observed pancreatic cancer patients' poor survivals were associated with PLR ≥ 160 and a high level of CA19-9. Compared to an elevation of each of the two CA19-9 and PLR markers, the worst survival outcome was even found with their combination (Smith et al., 2008) . Only one of the previous reports of PLR in EOC (Asher et al., 2011) was inconsistent with the significant results of pancreatic cancer obtained by Smith et al. (2008) .
On a study on preoperative PLR and NLR in 235 ovarian cancer patients, Asher et al. (2011) discovered a poor survival was significantly accompanied with age, stage, grade, absolute neutrophil count, platelet count, NLR (≥4), PLR (≥300), and surgical outcome. The only independent prognostic factors for survival were found to be PLR, stage, and residual disease. The different PLR statistical significances faced in all the mentioned studies might be due to the patients' different numbers or proportions of features, such as the disease stage and primary surgical results, thus leading to an unfavorable prognosis for those with high PLR levels. Anyhow, heterogeneity of early and advanced stage patients in the study communities was a common restriction in both Asher et al. (2011) and our studies. The small number of patients was another limitation in our research.
In the current clinical study, it was concluded that a poor prognosis was associated with an enhancement in all blood components in EOC surgery. Compared to NLR or thrombocytosis, PLR revealed to be a better independent prognostic indicator for EOC surgery in a univariable analysis, but not in a multivariable analysis. Thus, to corroborate the prognostic roles of blood components, further research in a larger and more homogeneous population is required.
